GlassScriptPhysician profile
Katelyn Jean Mcskane
NPI 1205430105
$2,025.91
in general payments reported to CMS, 2019-2025
12 companies · $30.03 in 2025
The $30.03 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $782 · 2024: $1,214 · 2025: $30.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,826 · Travel and Lodging: $191 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,825.86 |
| Travel and Lodging | $191.05 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $839.24 | 2023-2025 | |
| Curonix LLC | $481.57 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $225.20 | 2024 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $161.84 | 2023-2024 | Belbuca |
| Ipsen Biopharmaceuticals, INC | $89.63 | 2024 | Dysport |
| Valinor Pharma, LLC | $82.05 | 2023-2024 | Movantik |
| Merz Pharmaceuticals, LLC | $38.16 | 2023 | Xeomin |
| Stryker Corporation | $29.50 | 2024 | Mild Device Kit |
| Vertos Medical, INC. | $22.24 | 2024 | Mild Device Kit |
| Tersera Therapeutics LLC | $20.56 | 2024 | Prialt |
| Pfizer INC. | $18.56 | 2024 | |
| Scilex Pharmaceuticals INC. | $17.36 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Mcskane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.